(1 - 14 from 15
)
Exelixis Announces Phase 1 Trial Results for Cabozantinib in ...ir.exelixis.com › news-releases › news-release-details › exelixis-annou...
ir.exelixis.com
... new options,” said Andrea Apolo , M.D., Genitourinary Malignancies Branch, Center for Cancer Research , National Cancer Institute , the principal investigator ...
Press Release - Investor - Exelixis
ir.exelixis.com
Dr. Andrea Apolo , Center for Cancer Research , National Cancer Institute , Bethesda, MD Oral Abstract Session: Genitourinary Cancer Monday ...
Reminder: Cabozantinib to be Featured in Nine Presentations at the...
ir.exelixis.com
Dr. Andrea Apolo , Center for Cancer Research , National Cancer Institute , Bethesda, MD General Poster Session: Genitourinary (Nonprostate) Cancer (Trials in ...
sorted by relevance / date